Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e13-e15. doi: 10.1111/jdv.16953. Epub 2020 Oct 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Androgen Antagonists / therapeutic use*
  • COVID-19*
  • Dutasteride / therapeutic use
  • Finasteride / therapeutic use
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Observational Studies as Topic
  • Patient Admission*
  • Prospective Studies
  • SARS-CoV-2
  • Spironolactone / therapeutic use

Substances

  • Androgen Antagonists
  • Spironolactone
  • Finasteride
  • Dutasteride